(vianews) - essilorluxottica (el.pa) is among this list of stock assets with the highest dividend rate and return on equity on the healthcare sector.
| financial asset | price | forward dividend yield | return on equity |
|---|---|---|---|
| essilorluxottica (el.pa) | €209.70 | 1.95% | 6.3% |
| equasens (eqs.pa) | €51.30 | 1.89% | 27.25% |
several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. essilorluxottica (el.pa)
1.95% forward dividend yield and 6.3% return on equity
essilorluxottica société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in europe, the middle east, africa, latin america, the asia-pacific, and north america. it operates through professional solutions and direct to consumer segments. the company offers lens under the essilor, varilux, crizal, eyezen, stellest, xperio, transitions, ray-ban, oakley, barberini, kodak lens, nikon, shamir, eyexpert, iwear, humanware, and optifog brands. it also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the essilor instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the satisloh brand. in addition, the company provides eyewear products under the ray-ban, oakley, persol, oliver peoples, vogue eyewear, arnette, alain mikli, costa, bliz, native, luxottica, sferoflex, bolon, molsion, dbyd, and unofficial and seen, as well as other licensed brands. in addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. it wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. the company was formerly known as essilor international société anonyme and changed its name to essilorluxottica société anonyme in october 2018. essilorluxottica société anonyme was founded in 1849 and is headquartered in paris, france.
earnings per share
as for profitability, essilorluxottica has a trailing twelve months eps of €5.08.
pe ratio
essilorluxottica has a trailing twelve months price to earnings ratio of 41.28. meaning, the purchaser of the share is investing €41.28 for every euro of annual earnings.
return on equity
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.3%.
volatility
essilorluxottica's last week, last month's, and last quarter's current intraday variation average was a negative 0.51%, a negative 0.18%, and a positive 0.77%.
essilorluxottica's highest amplitude of average volatility was 0.95% (last week), 0.88% (last month), and 0.77% (last quarter).
more news about essilorluxottica.
2. equasens (eqs.pa)
1.89% forward dividend yield and 27.25% return on equity
equasens société anonyme provides healthcare it solutions in europe. it offers id. patient, a business software; id. mobility, a back-office management software; pandalab pro, an instant messaging solution; id. vente, an has-certified drug database; id. commande, an order management module; dispensing robots; services ségur id; id. dosage, a dosage management and printing module; multimeds reconditioning robot; compliance monitoring module; home delivery module; home equipment rental management module; visiodroits module; and website connector. the company also provides id. desk, an informative and interactive dashboard; id. up!, a real-time monitoring and control application of id management software; id. easyq, a queue management solution; miaterapia; id. show, an application for managing real-time communications on pharmacy screens; pharmaweb; tsgatepro; lmo, a dispensary business software; and lgo, a dispensary management software. in addition, it offers domilink had software; mobisoins mobility tool; memorialis, support software for alzheimer's monitoring teams; hospilink, an hospital information system applications; hospilink dpi, a computerized patient file; hospilink lookup big data; enephro solutions; noviacare solutions; kap&link2, a contact chip card reader terminal and nfc reader; es-kap-ad, a connected nomadic tool incorporating software; kap-inside, a mobile terminal; and ti-kap allowing access to contact and contactless cards. further, the company provides authenticator, a patented authentication system; kap'teur by kapelse, a patented universal sensor; expressvitale; médistory, that automates the transfer of invoicing to the healthcare professional's accounting. additionally, it offers medical telesecretarial services for healthcare professionals, as well as equipment lease financing solutions. the company was incorporated in 1996 and is headquartered in villers-les-nancy, france. equasens société anonyme is a subsidiary of marque verte sante.
earnings per share
as for profitability, equasens has a trailing twelve months eps of €3.2.
pe ratio
equasens has a trailing twelve months price to earnings ratio of 16.03. meaning, the purchaser of the share is investing €16.03 for every euro of annual earnings.
return on equity
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.25%.
stock price classification
according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, equasens's stock is considered to be oversold (<=20).
more news about equasens.